These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15094704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
    Agasti AK, Mahajan AU, Phadke AY, Nathani PJ, Sawant P.
    J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B.
    Gastroenterol Hepatol; 2000 May; 23(6):275-81. PubMed ID: 15324622
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis.
    Tripathi D, Therapondos G, Lui HF, Johnston N, Webb DJ, Hayes PC.
    Am J Gastroenterol; 2004 Feb; 99(2):390-4. PubMed ID: 15046234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.
    Kim JH, Kim JM, Cho YZ, Na JH, Kim HS, Kim HA, Kang HW, Baik SK, Kwon SO, Cha SH, Kim YJ, Kim MY.
    Clin Mol Hepatol; 2014 Dec; 20(4):376-83. PubMed ID: 25548744
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome.
    Piecha F, Mandorfer M, Peccerella T, Ozga AK, Poth T, Vonbank A, Seitz HK, Rausch V, Reiberger T, Mueller S.
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct 01; 315(4):G484-G494. PubMed ID: 29746172
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis].
    Castaño G, Viudez P, Carlevaro O, Ocampo C, Zandalazini H, Riccitelli M, Sookoian S, Frider B.
    Acta Gastroenterol Latinoam; 1998 Oct 01; 28(4):291-7. PubMed ID: 10347683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J.
    J Hepatol; 1996 Apr 01; 24(4):430-5. PubMed ID: 8738729
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.
    Luca A, García-Pagán JC, Feu F, Lopez-Talavera JC, Fernández M, Bru C, Bosch J, Rodés J.
    Hepatology; 1995 Jan 01; 21(1):83-8. PubMed ID: 7806173
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodés J, Bosch J.
    Hepatology; 2003 Apr 01; 37(4):902-8. PubMed ID: 12668985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.